lonafarnib has been researched along with anastrozole in 1 studies
| Studies (lonafarnib) | Trials (lonafarnib) | Recent Studies (post-2010) (lonafarnib) | Studies (anastrozole) | Trials (anastrozole) | Recent Studies (post-2010) (anastrozole) |
|---|---|---|---|---|---|
| 224 | 34 | 90 | 1,568 | 354 | 686 |
| Protein | Taxonomy | lonafarnib (IC50) | anastrozole (IC50) |
|---|---|---|---|
| Aromatase | Homo sapiens (human) | 0.1443 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.0036 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.0015 | |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | 4.72 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basso, AD; Black, S; Kirschmeier, P; Liu, G; Liu, M; Long, BJ; Marrinan, CH; Robert Bishop, W; Taylor, SA | 1 |
1 other study(ies) available for lonafarnib and anastrozole
| Article | Year |
|---|---|
Enhancement of the antitumor activity of tamoxifen and anastrozole by the farnesyltransferase inhibitor lonafarnib (SCH66336).
Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Apoptosis; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Synergism; Enzyme Inhibitors; Farnesyltranstransferase; Female; G1 Phase; Humans; In Situ Nick-End Labeling; Mice; Mice, Nude; Neoplasm Transplantation; Nitriles; Ovariectomy; Piperidines; Pyridines; S Phase; Tamoxifen; Triazoles | 2007 |